Assignee
GBS GLOBAL BIOPHARMA INC
CA·4 granted patents·10 pending applications·1 citations·filing 2018–2024
Top patents by PatentIndex Score
14 records- 0177US11260044B2TRPV1 activation-modulating complex mixtures of cannabinoids and/or terpenesGBS GLOBAL BIOPHARMA INC·Filed 2019·Granted Mar 1, 2022·1 cites·11 claims
- 0274US2025108016A1Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseasesGBS GLOBAL BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0366US2024316002A1Cannabinoid-Containing Formulations for Parkinsonian Movement DisordersGBS GLOBAL BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0463US11980592B2Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseasesGBS GLOBAL BIOPHARMA INC·Filed 2020·Granted May 14, 2024·0 cites·16 claims
- 0562US11944593B2Myrcene-containing complex mixtures targeting TRPV1GBS GLOBAL BIOPHARMA INC·Filed 2020·Granted Apr 2, 2024·0 cites·20 claims
- 0661US2024216398A1Cannabinoid-containing complex mixtures for the treatment of cytokine release syndrome while preserving key anti-viral immune reactionsGBS GLOBAL BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0761US2023263766A1Cannabinoid-containing formulations for parkinsonian movement disordersGBS GLOBAL BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0860US2022387375A1Trpv1 activation-modulating complex mixtures of cannabinoids and/or terpenesGBS GLOBAL BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0953US2022130493A1Method and systems for phytomedicine analytics for research optimization at scaleGBS GLOBAL BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1053US2021212961A1Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disordersGBS GLOBAL BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1151US2022110910A1Cannabinoid-containing complex mixtures for the treatment of cytokine release syndrome while preserving key anti-viral immune reactionsGBS GLOBAL BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1249US10857107B2Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disordersGBS GLOBAL BIOPHARMA INC·Filed 2018·Granted Dec 8, 2020·0 cites·11 claims
- 1348US2020155469A1Therapeutic nanoparticles encapsulating terpenoids and/or cannabinoidsGBS GLOBAL BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 1446US2020405657A1Treatment of pain using allosteric modulator of trpv1GBS GLOBAL BIOPHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GBS GLOBAL BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →